Sign in
4

Changes in Ownership

Aclaris Therapeutics, Inc. Filed Acc 0001209191-15-075195

Chief Legal Officer acquired 3,738 shares (conversion)

From the SEC's structured data for this filing

Trades in this filing

Ali-Jackson Kamil · Chief Legal Officer

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2015-10-13 Conversion : show line 1 in the form +3,738 24,027 D

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2015-10-13 Conversion : show line 2 in the form Series A Preferred Stock −10,000 0 D
2015-10-13 Conversion : show line 3 in the form Series B Preferred Stock −2,901 0 D
Loading xslF345X03/doc4.xml…